Live tape
Top 8, mentions 7d997GOOGL178 mentions▲ +0.05NVDA167 mentions▲ +0.10SPY149 mentions▲ +0.05QQQ120 mentions▲ +0.08META117 mentions▲ +0.05TSLA91 mentions▲ +0.06AMZN90 mentions▲ +0.04MSFT85 mentions▲ +0.07

Equity · Healthcare

BMY

Bristol-Myers Squibb Company · NYSE

$63.03 +0.32% 1D Finazon · prior-day close · Sep 18, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$70 $55 23 Jun 18 Sep

The line runs $55.54 on 23 June through $63.03 on 18 September, on a scale from $55 to $70. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BMY over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $55.54 on 23 June 2026 through $63.03 on 18 September 2026.

Market cap $128.8B
P/E (TTM) 13.6
52-week range $42.64 – $68.08
Avg volume 572.4K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 20, 2026

BMY insider trades

SEC Form 4 · last 90 days · newest reported trade 9 Sep 2026
Open-market buys 0
Open-market sells 2
Net sold $437K
Non-trade filings 6
Date Insider Type Shares Value
09 Sep 2026 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Sell 6,249 $403K
25 Aug 2026 Holzer Phil M SVP and Controller Sell 500 $34K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Sep 2026 Short Bartie Wendy EVP, Corporate Affairs Option exercise 1,236 $83K
01 Sep 2026 Short Bartie Wendy EVP, Corporate Affairs Tax withheld 633 $42K
01 Aug 2026 Gallman Cari EVP, General Counsel Option exercise 1,061
01 Aug 2026 Gallman Cari EVP, General Counsel Tax withheld 543 $35K
01 Aug 2026 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Option exercise 51,172
01 Aug 2026 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Tax withheld 26,175 $1.71M

BMY reported financials

SEC EDGAR XBRL

BMY reported revenue of $48.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $7.1B.

Figure Reported Period
Revenue $48.2B 31 Dec 2025 fiscal year
Net income $7.1B 31 Dec 2025 fiscal year
Diluted EPS $3.46 31 Dec 2025 fiscal year
Total assets $87.6B 30 Jun 2026 at period end
Total equity $22.3B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

BMY earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.62 $12.97B
31 Mar 2026 Q1 2026 $1.31 $11.49B
31 Dec 2025 FY 2025 $3.46 $48.19B
30 Sep 2025 Q3 2025 $1.08 $12.22B
30 Jun 2025 Q2 2025 $0.64 $12.27B
31 Mar 2025 Q1 2025 $1.20 $11.20B
31 Dec 2024 FY 2024 $-4.41 $48.30B
30 Sep 2024 Q3 2024 $0.60 $11.89B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BMY institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a BMY position for the quarter ended 30 Jun 2026 — a combined $2.6B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Held (±25%) −7.7% shares 27,357,486 $1.6B
Two Sigma Investments Held (±25%) −12.6% shares 10,085,383 $581.1M
Man Group Held (±25%) −17.3% shares 4,682,000 $269.8M
Citadel Advisors Held (±25%) +5.2% shares 1,572,329 $90.6M
Millennium Management Trimmed −88.5% shares 752,576 $43.4M
D. E. Shaw & Co. Added +80.5% shares 559,407 $32.2M
Fisher Asset Management Held (±25%) −14.9% shares 173,404 $10.0M
Balyasny Asset Management Trimmed −25.6% shares 88,288 $5.1M
GAMCO Investors Held (±25%) −5.0% shares 82,671 $4.8M
Marshall Wace Trimmed −99.6% shares 15,169 $874K

Source: SEC EDGAR 13F filings

BMY fails-to-deliver

SEC CNS data

On 24 Aug 2026, 73,519 shares of BMY failed to deliver (about $4.9M).

Settlement date Shares failed Notional % of shares out
24 Aug 2026 73,519 $4.9M 0.004%
20 Aug 2026 88,820 $6.0M 0.004%
13 Aug 2026 301 $19K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in BMY

STOCK Act disclosures

The most recent congressional trade disclosed in BMY is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 19 Dec 2025.

Date Member Type Amount
19 Dec 2025 filed 12 Jan 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
18 Dec 2025 filed 15 Jan 2026 Julie Johnson house · Democrat–TX Sale $1K–$15K
28 Apr 2025 filed 13 Jan 2026 Julia Letlow house · Republican–LA Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures